206 related articles for article (PubMed ID: 33608612)
1. AT
Kratky V; Vanourkova Z; Sykora M; Bacova BS; Hruskova Z; Kikerlova S; Huskova Z; Kopkan L
Sci Rep; 2021 Feb; 11(1):4271. PubMed ID: 33608612
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L
Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914
[TBL] [Abstract][Full Text] [Related]
3. Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula.
Honetschlagerová Z; Gawrys O; Jíchová Š; Škaroupková P; Kikerlová S; Vaňourková Z; Husková Z; Melenovský V; Kompanowska-Jezierska E; Sadowski J; Kolář F; Novotný J; Hejnová L; Kujal P; Červenka L
Kidney Blood Press Res; 2021; 46(1):95-113. PubMed ID: 33530085
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
5. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
Vacková Š; Kikerlová S; Melenovsky V; Kolář F; Imig JD; Kompanowska-Jezierska E; Sadowski J; Červenka L
Kidney Blood Press Res; 2019; 44(4):792-809. PubMed ID: 31430751
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
Yamamoto K; Mano T; Yoshida J; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
[TBL] [Abstract][Full Text] [Related]
7. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
Kala P; Gawrys O; Miklovič M; Vaňourková Z; Škaroupková P; Jíchová Š; Sadowski J; Kompanowska-Jezierska E; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L
J Hypertens; 2023 Jan; 41(1):99-114. PubMed ID: 36204993
[TBL] [Abstract][Full Text] [Related]
8. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.
Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L
Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740
[TBL] [Abstract][Full Text] [Related]
9. Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
Honetschlägerová Z; Sadowski J; Kompanowska-Jezierska E; Maxová H; Táborský M; Kujal P; Červenka L
Hypertens Res; 2023 Oct; 46(10):2340-2355. PubMed ID: 37592042
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J
Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375
[TBL] [Abstract][Full Text] [Related]
11. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
[TBL] [Abstract][Full Text] [Related]
12. Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome: insight from studies with Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
Honetschlägerová Z; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Táborský M; Vaňourková Z; Kujal P; Červenka L
Hypertens Res; 2024 Apr; 47(4):998-1016. PubMed ID: 38302775
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure.
Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Miwa T; Hori M; Masuyama T
Hypertension; 2004 Mar; 43(3):686-91. PubMed ID: 14757777
[TBL] [Abstract][Full Text] [Related]
15. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.
Jacinto SM; Mullins JJ; Mitchell KD
Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963
[TBL] [Abstract][Full Text] [Related]
16. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.
Funabiki K; Onishi K; Dohi K; Koji T; Imanaka-Yoshida K; Ito M; Wada H; Isaka N; Nobori T; Nakano T
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2487-92. PubMed ID: 15548724
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
19. Effects of Renal Denervation on the Enhanced Renal Vascular Responsiveness to Angiotensin II in High-Output Heart Failure: Angiotensin II Receptor Binding Assessment and Functional Studies in Ren-2 Transgenic Hypertensive Rats.
Honetschlägerová Z; Hejnová L; Novotný J; Marek A; Červenka L
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944619
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress.
Yagi S; Morita T; Katayama S
Hypertens Res; 2004 Feb; 27(2):129-35. PubMed ID: 15005276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
